Bildkälla: Stockfoto

Episurf Medical Q2: Continues to prepare for the next phase - Redeye

Redeye comments on Episurf’s Q2 report and notes a quarter in line with our expectations both financially and in terms of activities. The company is preparing for a more intensified commercial phase, and we see several exciting activities in the coming months. We reiterate our fair value range.

Redeye comments on Episurf’s Q2 report and notes a quarter in line with our expectations both financially and in terms of activities. The company is preparing for a more intensified commercial phase, and we see several exciting activities in the coming months. We reiterate our fair value range.
Börsvärldens nyhetsbrev
ANNONSER